These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33262468)

  • 1. Somatic mutations cause VEXAS syndrome.
    Onuora S
    Nat Rev Rheumatol; 2021 Jan; 17(1):1. PubMed ID: 33262468
    [No Abstract]   [Full Text] [Related]  

  • 2. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RF - VEXAS Syndrome: A New Autoinflammatory Disease.
    Fernández-Parrado M; Perandones-González H
    Actas Dermosifiliogr; 2023 Jun; 114(6):531-532. PubMed ID: 36572144
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.
    Sikora KA; Wells KV; Bolek EC; Jones AI; Grayson PC
    Rheumatology (Oxford); 2022 Aug; 61(8):3149-3160. PubMed ID: 34888629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical splice-site mutations causing VEXAS syndrome.
    Templé M; Duroyon E; Croizier C; Rossignol J; Huet T; Friedrich C; Zalmai L; Priollet P; Hayem G; Tournillhac O; Le Guenno G; Hermine O; Terrier B; Kosmider O
    Rheumatology (Oxford); 2021 Dec; 60(12):e435-e437. PubMed ID: 34213531
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloid and lymphoid vacuolation in VEXAS syndrome.
    Fan BE; Cao L; Gallardo CA; Lee SMS; Koh LW; Goh LL; Ong KH; Kuperan P
    Am J Hematol; 2021 Aug; 96(8):1056-1057. PubMed ID: 33460492
    [No Abstract]   [Full Text] [Related]  

  • 8. VEXAS syndrome: still expanding the clinical phenotype.
    Oganesyan A; Jachiet V; Chasset F; Hirsch P; Hage-Sleiman M; Fabiani B; Duriez P; Georgin-Lavialle S; Delhommeau F; Hakobyan Y; Fain O; Mekinian A;
    Rheumatology (Oxford); 2021 Sep; 60(9):e321-e323. PubMed ID: 33693570
    [No Abstract]   [Full Text] [Related]  

  • 9. Extensive Multiple Organ Involvement in VEXAS Syndrome.
    Takahashi N; Takeichi T; Nishida T; Sato J; Takahashi Y; Yamamura M; Ogi T; Akiyama M
    Arthritis Rheumatol; 2021 Oct; 73(10):1896-1897. PubMed ID: 33881233
    [No Abstract]   [Full Text] [Related]  

  • 10. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndrome.
    Alhomida F; Beck DB; George TI; Shaffer A; Lebiedz-Odrobina D; Kovacsovics T; Madigan LM
    JAAD Case Rep; 2021 Aug; 14():111-113. PubMed ID: 34337120
    [No Abstract]   [Full Text] [Related]  

  • 11. VEXAS within the spectrum of rheumatologic disease.
    Koster MJ; Warrington KJ
    Semin Hematol; 2021 Oct; 58(4):218-225. PubMed ID: 34802543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEXAS syndrome: lessons learnt from an early Australian case series.
    Islam S; Cullen T; Sumpton D; Damodaran A; Heath D; Bosco A; Doo NW; Kidson-Gerber G; Cheong A; Lawford R; Walsh R; Sammel A
    Intern Med J; 2022 Apr; 52(4):658-662. PubMed ID: 35419965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers.
    Papa R; Rusmini M; Volpi S; Caorsi R; Picco P; Grossi A; Caroli F; Bovis F; Musso V; Obici L; Castana C; Ravelli A; Van Gijn ME; Ceccherini I; Gattorno M
    Rheumatology (Oxford); 2020 Feb; 59(2):344-360. PubMed ID: 31325311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEXAS syndrome with cutaneous nodules.
    Argobi Y
    Dermatol Reports; 2022 Jun; 14(2):9414. PubMed ID: 35795842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Mosaicism Screening Using Single-Molecule Molecular Inversion Probes in Routine Diagnostics for Systemic Autoinflammatory Diseases.
    Kant B; Carbo EC; Kokmeijer I; Oosterman JJM; Frenkel J; Swertz MA; Ploos van Amstel JK; Aróstegui JI; Koudijs MJ; van Gijn ME
    J Mol Diagn; 2019 Nov; 21(6):943-950. PubMed ID: 31442672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [VEXAS syndrome].
    Zeeck M; Kötter I; Krusche M
    Z Rheumatol; 2022 Nov; 81(9):782-786. PubMed ID: 35179640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
    Karacan İ; Balamir A; Uğurlu S; Aydın AK; Everest E; Zor S; Önen MÖ; Daşdemir S; Özkaya O; Sözeri B; Tufan A; Yıldırım DG; Yüksel S; Ayaz NA; Ömeroğlu RE; Öztürk K; Çakan M; Söylemezoğlu O; Şahin S; Barut K; Adroviç A; Seyahi E; Özdoğan H; Kasapçopur Ö; Turanlı ET
    Rheumatol Int; 2019 May; 39(5):911-919. PubMed ID: 30783801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.
    Shinar Y; Ceccherini I; Rowczenio D; Aksentijevich I; Arostegui J; Ben-Chétrit E; Boursier G; Gattorno M; Hayrapetyan H; Ida H; Kanazawa N; Lachmann HJ; Mensa-Vilaro A; Nishikomori R; Oberkanins C; Obici L; Ohara O; Ozen S; Sarkisian T; Sheils K; Wolstenholme N; Zonneveld-Huijssoon E; van Gijn ME; Touitou I
    Clin Chem; 2020 Apr; 66(4):525-536. PubMed ID: 32176780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome.
    de Kock L; Wang YC; Revil T; Badescu D; Rivera B; Sabbaghian N; Wu M; Weber E; Sandoval C; Hopman SM; Merks JH; van Hagen JM; Bouts AH; Plager DA; Ramasubramanian A; Forsmark L; Doyle KL; Toler T; Callahan J; Engelenberg C; Bouron-Dal Soglio D; Priest JR; Ragoussis J; Foulkes WD
    J Med Genet; 2016 Jan; 53(1):43-52. PubMed ID: 26475046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome.
    Goyal A; Narayanan D; Wong W; Laga AC; Connell NT; Ritter SY; Cobos G
    JAAD Case Rep; 2022 May; 23():15-19. PubMed ID: 35391910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.